Results 171 to 180 of about 1,246,477 (257)
A study of Chinese law on restricting personal liberty for public health protection: taking the COVID-19 epidemic as the entry point. [PDF]
Liu T, Ma Z.
europepmc +1 more source
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch +5 more
wiley +1 more source
Research on the impact of policy tools on health protection behavior of the middle-aged and older adults in the city. [PDF]
Wu R, Yi K, Yang Y, Wang S.
europepmc +1 more source
Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST‐2, SPACE‐2, and ECST‐2
ABSTRACT Background Recent randomized trials (CREST‐2, SPACE‐2, and ECST‐2) have compared carotid revascularization (carotid endarterectomy [CEA] or carotid artery stenting [CAS]) plus contemporary medical therapy (CMT) versus CMT alone in asymptomatic carotid stenosis.
Aasim Ali +14 more
wiley +1 more source
Modeling and forecasting air pollution for public health protection based on ML and time series models in Gulf Cooperation Council (GCC) countries. [PDF]
Daniyal M +5 more
europepmc +1 more source
Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali +4 more
wiley +1 more source
<i>Staphylococci</i> in Livestock: Molecular Epidemiology, Antimicrobial Resistance, and Translational Strategies for One Health Protection. [PDF]
Elbehiry A, Marzouk E.
europepmc +1 more source
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine +40 more
wiley +1 more source

